{"schema_version":"secwatch.filing_event.v1","accession":"0000950142-23-000586","form_type":"8-K","ticker":"NRXP","cik":"0001719406","company_name":"NRX Pharmaceuticals, Inc.","filed_at":"2023-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.299002+00:00","generated_at":"2026-06-18T13:17:14.928008+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.15,"confidence":"high","headline":"NRx Pharma shareholders approve stock issuance to Streeterville Capital","bullets":["Stockholders approved issuance of common shares to Streeterville Capital, LLC under Nasdaq Listing Rule 5635(d).","Vote results: 38,338,555 for, 311,870 against, 373,843 abstentions.","Special meeting reconvened on March 3, 2023, with quorum present throughout.","Approval allows company to proceed with share issuance, potentially for financing or debt conversion."],"urls":{"canonical":"https://secwatch.observer/filing/0000950142-23-000586","json":"https://secwatch.observer/filing/0000950142-23-000586.json","markdown":"https://secwatch.observer/filing/0000950142-23-000586.md","text":"https://secwatch.observer/filing/0000950142-23-000586.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1719406/000095014223000586/0000950142-23-000586-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1719406/000095014223000586/eh230336011_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T13:17:14.928008+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1d13444e76dcd52ec2fa30562b92715411cab8c8","claim":"NRX Pharmaceuticals, Inc. shareholders approved Approval of issuance of shares of common stock to Streeterville Capital, LLC in accordance with Nasdaq Listing Rule 5635(d) at the 2023-03-03 meeting.","evidence_excerpt":"The Company’s stockholders approved approve the issuance of shares of common stock to Streeterville Capital, LLC in accordance with Nasdaq Listing Rule 5635(d). The results of the voting were as follows: Votes For Votes Against Abstentions 38,338,555 311,870 373,843","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1719406/000095014223000586/0000950142-23-000586-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-03-03"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}